Header Logo

Connection

Karen Wernli to Humans

Back to Details
This is a "connection" page, showing publications Karen Wernli has written about Humans.
Karen Wernli
Connection Strength
1.651
Humans
  1. Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density. Breast Cancer Res Treat. 2022 Aug; 194(3):607-616.
    View in: PubMed
    Score: 0.059
  2. Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening. Perm J. 2021 Jun 02; 25.
    View in: PubMed
    Score: 0.055
  3. Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer. 2020 12 15; 126(24):5293-5302.
    View in: PubMed
    Score: 0.053
  4. Surveillance for second breast cancer events in women with a personal history of breast cancer using breast MRI: a systematic review and meta-analysis. Breast Cancer Res Treat. 2020 Jun; 181(2):255-268.
    View in: PubMed
    Score: 0.051
  5. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". J Gen Intern Med. 2020 06; 35(6):1654-1660.
    View in: PubMed
    Score: 0.050
  6. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 10; 34(10):2098-2106.
    View in: PubMed
    Score: 0.049
  7. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 08; 292(2):311-318.
    View in: PubMed
    Score: 0.048
  8. A qualitative study exploring patient motivations for screening for lung cancer. PLoS One. 2018; 13(7):e0196758.
    View in: PubMed
    Score: 0.045
  9. From Principles to Practice: Real-World Patient and Stakeholder Engagement in Breast Cancer Research. Perm J. 2018; 22:17-232.
    View in: PubMed
    Score: 0.044
  10. A systematic multidisciplinary initiative for reducing the risk of complications in adult scoliosis surgery. J Neurosurg Spine. 2017 Jun; 26(6):744-750.
    View in: PubMed
    Score: 0.041
  11. Change in Breast Cancer Screening Intervals Since the 2009 USPSTF Guideline. J Womens Health (Larchmt). 2017 08; 26(8):820-827.
    View in: PubMed
    Score: 0.041
  12. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2016 Jul 26; 316(4):436-47.
    View in: PubMed
    Score: 0.039
  13. Risks Associated With Anesthesia Services During Colonoscopy. Gastroenterology. 2016 Apr; 150(4):888-94; quiz e18.
    View in: PubMed
    Score: 0.038
  14. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1230-7.
    View in: PubMed
    Score: 0.034
  15. Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2014 Jan; 174(1):125-32.
    View in: PubMed
    Score: 0.033
  16. Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst. 2014 Jan; 106(1):djt341.
    View in: PubMed
    Score: 0.033
  17. Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer. Cancer Epidemiol Biomarkers Prev. 2013 Sep; 22(9):1638-41.
    View in: PubMed
    Score: 0.032
  18. Anesthesia for colonoscopy: too much of a good thing? JAMA Intern Med. 2013 Apr 08; 173(7):556-8.
    View in: PubMed
    Score: 0.031
  19. Suspected extracolonic neoplasms detected on CT colonography: literature review and possible outcomes. Acad Radiol. 2013 Jun; 20(6):667-74.
    View in: PubMed
    Score: 0.031
  20. Timing of follow-up after abnormal screening and diagnostic mammograms. Am J Manag Care. 2011 Feb; 17(2):162-7.
    View in: PubMed
    Score: 0.027
  21. Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):131-7.
    View in: PubMed
    Score: 0.027
  22. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res. 2010 Aug; 20(4):305-9.
    View in: PubMed
    Score: 0.026
  23. The relationship between gravidity and parity and colorectal cancer risk. J Womens Health (Larchmt). 2009 Jul; 18(7):995-1001.
    View in: PubMed
    Score: 0.024
  24. Antidepressant medication use and breast cancer risk. Pharmacoepidemiol Drug Saf. 2009 Apr; 18(4):284-90.
    View in: PubMed
    Score: 0.024
  25. Occupational risk factors for endometrial cancer among textile workers in Shanghai, China. Am J Ind Med. 2008 Sep; 51(9):673-9.
    View in: PubMed
    Score: 0.023
  26. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer. 2008 Jun 03; 98(11):1781-3.
    View in: PubMed
    Score: 0.022
  27. Occupational exposures and ovarian cancer in textile workers. Epidemiology. 2008 Mar; 19(2):244-50.
    View in: PubMed
    Score: 0.022
  28. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug; 19(6):605-13.
    View in: PubMed
    Score: 0.022
  29. Development of a job exposure matrix (JEM) for the textile industry in Shanghai, China. J Occup Environ Hyg. 2006 Oct; 3(10):521-9.
    View in: PubMed
    Score: 0.020
  30. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women. Cancer Causes Control. 2006 Sep; 17(7):949-55.
    View in: PubMed
    Score: 0.020
  31. Occupational risk factors for esophageal and stomach cancers among female textile workers in Shanghai, China. Am J Epidemiol. 2006 Apr 15; 163(8):717-25.
    View in: PubMed
    Score: 0.019
  32. Cancer among women textile workers in Shanghai, China: overall incidence patterns, 1989-1998. Am J Ind Med. 2003 Dec; 44(6):595-9.
    View in: PubMed
    Score: 0.016
  33. Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. 2023 04 01; 151(4).
    View in: PubMed
    Score: 0.016
  34. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020. Emerg Infect Dis. 2023 Feb; 29(2):278-285.
    View in: PubMed
    Score: 0.015
  35. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. J Clin Oncol. 2023 Feb 01; 41(4):859-870.
    View in: PubMed
    Score: 0.015
  36. Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study. J Womens Health (Larchmt). 2022 11; 31(11):1547-1556.
    View in: PubMed
    Score: 0.015
  37. Cross-ancestry Genome-wide Association Studies of Sex Hormone Concentrations in Pre- and Postmenopausal Women. Endocrinology. 2022 Apr 01; 163(4).
    View in: PubMed
    Score: 0.015
  38. Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. J Natl Compr Canc Netw. 2022 04; 20(4):379-386.e9.
    View in: PubMed
    Score: 0.015
  39. Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
    View in: PubMed
    Score: 0.015
  40. Preoperative MRI in breast cancer: effect of breast density on biopsy rate and yield. Breast Cancer Res Treat. 2022 Jan; 191(1):177-190.
    View in: PubMed
    Score: 0.014
  41. Cancer Informatics for Cancer Centers: Scientific Drivers for Informatics, Data Science, and Care in Pediatric, Adolescent, and Young Adult Cancer. JCO Clin Cancer Inform. 2021 08; 5:881-896.
    View in: PubMed
    Score: 0.014
  42. Women's considerations and experiences for breast cancer screening and surveillance during the COVID-19 pandemic in the United States: A focus group study. Prev Med. 2021 10; 151:106542.
    View in: PubMed
    Score: 0.014
  43. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity. JAMA Netw Open. 2021 03 01; 4(3):e211974.
    View in: PubMed
    Score: 0.014
  44. Evaluation of existing patient educational materials and development of a brochure for women with dense breasts. Breast. 2020 Apr; 50:81-84.
    View in: PubMed
    Score: 0.013
  45. Facility Variability in Examination Indication Among Women With Prior Breast Cancer: Implications and the Need for Standardization. J Am Coll Radiol. 2020 Jun; 17(6):755-764.
    View in: PubMed
    Score: 0.013
  46. Prior breast density awareness, knowledge, and communication in a health system-embedded behavioral intervention trial. Cancer. 2020 04 15; 126(8):1614-1621.
    View in: PubMed
    Score: 0.013
  47. Preoperative breast MRI and mortality in older women with breast cancer. Breast Cancer Res Treat. 2018 Jul; 170(1):149-157.
    View in: PubMed
    Score: 0.011
  48. Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt). 2018 06; 27(6):748-754.
    View in: PubMed
    Score: 0.011
  49. Preoperative Breast Magnetic Resonance Imaging Use by Breast Density and Family History of Breast Cancer. J Womens Health (Larchmt). 2018 08; 27(8):987-993.
    View in: PubMed
    Score: 0.011
  50. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec; 116(8):1008-1015.
    View in: PubMed
    Score: 0.011
  51. Performance Benchmarks for Screening Breast MR Imaging in Community Practice. Radiology. 2017 10; 285(1):44-52.
    View in: PubMed
    Score: 0.010
  52. A qualitative study exploring why individuals opt out of lung cancer screening. Fam Pract. 2017 04 01; 34(2):239-244.
    View in: PubMed
    Score: 0.010
  53. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326.
    View in: PubMed
    Score: 0.010
  54. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system. Contemp Clin Trials. 2017 05; 56:25-33.
    View in: PubMed
    Score: 0.010
  55. Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer. Med Care. 2016 07; 54(7):719-24.
    View in: PubMed
    Score: 0.010
  56. Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S. Prev Med. 2016 08; 89:169-177.
    View in: PubMed
    Score: 0.010
  57. Costs of diagnostic and preoperative workup with and without breast MRI in older women with a breast cancer diagnosis. BMC Health Serv Res. 2016 Feb 27; 16:76.
    View in: PubMed
    Score: 0.010
  58. Concordance of BI-RADS Assessments and Management Recommendations for Breast MRI in Community Practice. AJR Am J Roentgenol. 2016 Jan; 206(1):211-6.
    View in: PubMed
    Score: 0.009
  59. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. 2016 Feb 15; 122(4):611-7.
    View in: PubMed
    Score: 0.009
  60. Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers. AJR Am J Roentgenol. 2015 Sep; 205(3):676-84.
    View in: PubMed
    Score: 0.009
  61. Occupational exposures and risk of stomach and esophageal cancers: update of a cohort of female textile workers in Shanghai, China. Am J Ind Med. 2015 Mar; 58(3):267-75.
    View in: PubMed
    Score: 0.009
  62. Shift work and breast cancer among women textile workers in Shanghai, China. Cancer Causes Control. 2015 Jan; 26(1):143-50.
    View in: PubMed
    Score: 0.009
  63. Breast MRI BI-RADS assessments and abnormal interpretation rates by clinical indication in US community practices. Acad Radiol. 2014 Nov; 21(11):1370-6.
    View in: PubMed
    Score: 0.009
  64. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58.
    View in: PubMed
    Score: 0.008
  65. Use of interactive voice response to improve colorectal cancer screening. Med Care. 2014 Jun; 52(6):496-9.
    View in: PubMed
    Score: 0.008
  66. Occupational exposure to magnetic fields and breast cancer among women textile workers in Shanghai, China. Am J Epidemiol. 2013 Oct 01; 178(7):1038-45.
    View in: PubMed
    Score: 0.008
  67. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer. 2013 Nov 15; 119(22):3959-67.
    View in: PubMed
    Score: 0.008
  68. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013 May 13; 173(9):807-16.
    View in: PubMed
    Score: 0.008
  69. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst. 2013 Mar 06; 105(5):334-41.
    View in: PubMed
    Score: 0.008
  70. Common single-nucleotide polymorphisms in the estrogen receptor ß promoter are associated with colorectal cancer survival in postmenopausal women. Cancer Res. 2013 Jan 15; 73(2):767-75.
    View in: PubMed
    Score: 0.008
  71. Patient-centered outcomes in imaging: quantifying value. J Am Coll Radiol. 2012 Oct; 9(10):725-8.
    View in: PubMed
    Score: 0.008
  72. The impact of obesity on follow-up after an abnormal screening mammogram. Cancer Epidemiol Biomarkers Prev. 2012 Feb; 21(2):327-36.
    View in: PubMed
    Score: 0.007
  73. Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer. 2011 Mar 01; 104(5):763-8.
    View in: PubMed
    Score: 0.007
  74. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer. 2011; 63(4):583-92.
    View in: PubMed
    Score: 0.007
  75. Lung cancer and occupational exposures other than cotton dust and endotoxin among women textile workers in Shanghai, China. Occup Environ Med. 2011 Jun; 68(6):425-9.
    View in: PubMed
    Score: 0.007
  76. Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group. Cancer Epidemiol Biomarkers Prev. 2010 Jul; 19(7):1665-7.
    View in: PubMed
    Score: 0.006
  77. Re: Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2010 Jun 16; 102(12):913-4.
    View in: PubMed
    Score: 0.006
  78. Physical activity, physical exertion, and miscarriage risk in women textile workers in Shanghai, China. Am J Ind Med. 2010 May; 53(5):497-505.
    View in: PubMed
    Score: 0.006
  79. Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk. World J Gastroenterol. 2009 May 21; 15(19):2336-9.
    View in: PubMed
    Score: 0.006
  80. Dust and chemical exposures, and miscarriage risk among women textile workers in Shanghai, China. Occup Environ Med. 2009 Mar; 66(3):161-8.
    View in: PubMed
    Score: 0.006
  81. Oral contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2009 Feb; 20(1):27-34.
    View in: PubMed
    Score: 0.006
  82. Monthly injectable contraceptives and the risk of all cancers combined and site-specific cancers in Shanghai. Contraception. 2007 Jul; 76(1):40-4.
    View in: PubMed
    Score: 0.005
  83. Occupational exposures and breast cancer among women textile workers in Shanghai. Epidemiology. 2007 May; 18(3):383-92.
    View in: PubMed
    Score: 0.005
  84. Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2007 Mar 07; 99(5):357-64.
    View in: PubMed
    Score: 0.005
  85. Induced abortions and the risk of all cancers combined and site-specific cancers in Shanghai. Cancer Causes Control. 2006 Dec; 17(10):1275-80.
    View in: PubMed
    Score: 0.005
  86. Risks of biliary tract cancer and occupational exposures among Shanghai women textile workers: a case-cohort study. Am J Ind Med. 2006 Aug; 49(8):690-8.
    View in: PubMed
    Score: 0.005
  87. Occupational risk factors for pancreatic cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Dec; 63(12):788-93.
    View in: PubMed
    Score: 0.005
  88. Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, China. Scand J Work Environ Health. 2006 Jun; 32(3):178-84.
    View in: PubMed
    Score: 0.005
  89. Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China. Occup Environ Med. 2006 Jan; 63(1):39-44.
    View in: PubMed
    Score: 0.005
  90. Occupational exposures and risks of liver cancer among Shanghai female textile workers--a case-cohort study. Int J Epidemiol. 2006 Apr; 35(2):361-9.
    View in: PubMed
    Score: 0.005
  91. Colorectal cancer incidence among female textile workers in Shanghai, China: a case-cohort analysis of occupational exposures. Cancer Causes Control. 2005 Dec; 16(10):1177-88.
    View in: PubMed
    Score: 0.005
  92. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health. 2006 Mar; 79(3):251-8.
    View in: PubMed
    Score: 0.005
  93. Development of a cancer research study in the Shanghai textile industry. Int J Occup Environ Health. 2003 Oct-Dec; 9(4):347-56.
    View in: PubMed
    Score: 0.004

© 2024 Kaiser Permanente